Skip to main content

Advertisement

Table 1 Clinical and pathological characteristics of the 77 patients receiving radiotherapy, with or without the development of local recurrence

From: Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy

All LR+RT+ LR-RT+
Time to local recurrence, months n = 30 n = 47
   Median    
   Range 50 -
Follow-up, months 8–149 -
   Median    
   Range - 85
Tamoxifen - 62–231
Chemotherapy 6 1
Tamoxifen and chemotherapy 0 0
No adjuvant treatment 0 0
  24 46
Inclusion 1 and 2 Inclusion 1 Inclusion 2 Inclusion 1
Menopause    
   Pre 12 5 13
   Post 7 1 33
   Not available 0 5 1
Age at operation, years    
   Median 48 47 57
   Range 27–63 34–73 33–73
Size, millimeters    
   Median 14 15 15
   Range 2–32 10–20 4–22
   Not available 0 2a 0
Grade    
   1 3 3 22
   2 8 6 13
   3 7 1 10
   Not available 1 1 2
Estrogen receptor    
   Positive 9 11 42
   Negative 10 0 5
Progesterone receptor    
   Positive 5 9 31
   Negative 13 2 11
   Not available 1 0 5
Health care region    
   South 8 2 30
   West 2 0 9
   South-East 0 9 0
   Stockholm 9 0 8
  1. aOne T1 and one T2. LR-RT+ = no local recurrence after radiotherapy; LR+RT+ = local recurrence developed after radiotherapy.